Allied Market Research published a report, titled, "Cytogenetics Market by Product (Consumable, Instrument, Software and Service), by Technique (Comparative Genome Hybridization, Fluorescence in Situ ...

Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...

The technology, FISH-scRACS-seq (Fluorescence In Situ Hybridization-guided Single-Cell Raman-activated Sorting and Sequencing), utilizes a Raman-activated optical tweezers-based cell sorter ...

Molecular Instruments® (MI), founded by the inventor of the HCR technology, today announces the launch of the HCR Gold and HCR Pro product lines. These offerings significantly expand the HCR imaging ...

The global fluorescent in situ hybridization (FISH) probe market size was valued at $0.9 billion in 2023, and is projected to reach $1.8 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

in order to investigate the efficacy and tolerance of trastuzumab in combination with paclitaxel and carboplatin in patients with HER2-positive (fluorescence in situ hybridization [FISH] positive ...

The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for ...

Roche has announced that the FDA has expanded the approval of its PATHWAY® HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test to identify HE ...